(Q40985515)

English

The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection

scientific article published on 30 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection (English)

1 reference

Europe PubMed Central

25 September 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Mahmoud Abu-Amara

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Orlando Cerocchi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Gurtej Malhi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Suraj Sharma

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Colina Yim

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hemant Shah

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Harry L A Janssen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jordan J Feld

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

0 references

publication date

30 April 2015

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

65

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1347-1358

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Hepatocellular carcinoma: A global view.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-309099

21 January 2018

Identifiers

10.1136/GUTJNL-2014-309099

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934760%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40985515&oldid=2092871397"